{"filing":{"accession_number":"0001628280-26-044414","cik":"0001822359","ticker":"DCGO","company_name":"DocGo Inc.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"dcgo-20260616.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1822359/000162828026044414/dcgo-20260616.htm"},"events":[{"id":11976,"run_id":10539,"accession_number":"0001628280-26-044414","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure reporting the results of DocGo's 2026 Annual Meeting of Stockholders held on June 16, 2026. The filing presents voting outcomes on six matters: election of two Class II directors (Vina Leite and James M. Travers), advisory approval of named executive officer compensation, approval of a reverse stock split (1-for-5 to 1-for-10), rejection of a corporate opportunity waiver amendment, rejection of an officer exculpation amendment, and ratification of Urish Popeck \u0026 Co., LLC as independent auditor. The reverse stock split approval and director elections are material corporate governance events affecting shareholder interests.","company_name":"DocGo Inc.","ticker":"DCGO","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8704,"accession_number":"0001628280-26-044414","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of DocGo's 2026 Annual Meeting of Stockholders held on June 16, 2026. The filing presents voting outcomes on six matters: election of two Class II directors (Vina Leite and James M. Travers), advisory approval of named executive officer compensation, approval of a reverse stock split (1-for-5 to 1-for-10), rejection of a corporate opportunity waiver amendment, rejection of an officer exculpation amendment, and ratification of Urish Popeck \u0026 Co., LLC as independent auditor. The reverse stock split approval and director elections are material corporate governance events affecting shareholder interests.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T21:07:01.104680+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8704,"accession_number":"0001628280-26-044414","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of DocGo's 2026 Annual Meeting of Stockholders held on June 16, 2026. The filing presents voting outcomes on six matters: election of two Class II directors (Vina Leite and James M. Travers), advisory approval of named executive officer compensation, approval of a reverse stock split (1-for-5 to 1-for-10), rejection of a corporate opportunity waiver amendment, rejection of an officer exculpation amendment, and ratification of Urish Popeck \u0026 Co., LLC as independent auditor. The reverse stock split approval and director elections are material corporate governance events affecting shareholder interests.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T21:07:01.104680+00:00","company_name":"DocGo Inc.","ticker":"DCGO","filing_date":"2026-06-18"}]}